Chronic Kidney Disease-Anemia – Epidemiology Forecast to 2029
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The diagnosed prevalent cases of chronic kidney disease-anemia (CKD-anemia) in the eight major markets (*8MM) are projected to increase from four million cases in 2019 to 4.5 million cases in 2029, equating to an annual growth rate (AGR) of 1.13%. This report reveals that in 2029, China will have the highest number of diagnosed prevalent cases of CKD-anemia in the 8MM at two million, whereas the UK with nearly 74,000 cases will have the lowest number of these cases. The number of diagnosed prevalent cases of CKD-anemia was higher in women than in men in the 8MM combined, though there are variations in the predominant sex by market. This is driven by differences in the diagnosed prevalent cases of CKD by sex, as well as underlying demographic differences in these markets.
Shilpa Shaji, MPH, Epidemiologist at GlobalData, comments: “Anemia may begin to develop in the early stages of CKD and it tends to worsen as CKD progresses.
“Even though CKD-anemia has been associated with substantial morbidity and mortality, with appropriate treatment modalities such as iron therapy and erythropoiesis-stimulating agents, anemia can be effectively treated and thus the patients’ quality of life can be improved.”
*8MM: The US, 5EU (France, Germany, Italy, Spain, UK), Japan and China
Scope
The CKD-Anemia Epidemiology Report and Model provide an overview of the risk factors and global trends of chronic kidney disease-anemia (CKD-anemia) in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China).
The report includes a 10-year epidemiology forecast for the diagnosed prevalent cases of CKD-anemia. The diagnosed prevalent cases of CKD-anemia are segmented by age (≥18 years), sex, stage, as well as by cause of anemia (kidney-related causes and other causes), and by dialysis dependency (dialysis-dependent and non-dialysis-dependent) in the 8MM. The model additionally provides diagnosed and total prevalent cases of CKD segmented by age (≥18 years), sex, and stage.
The CKD-anemia epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons to Buy
The CKD-Anemia Epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global CKD-anemia markets.
- Quantify patient populations in the global CKD-anemia markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for CKD-anemia therapeutics in each of the markets covered.
- Understand magnitude of CKD-anemia population by its severity.
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.